Resistance to antivirals in human cytomegalovirus: mechanisms and clinical significance
- PMID: 9353754
Resistance to antivirals in human cytomegalovirus: mechanisms and clinical significance
Abstract
Long term therapies needed for managing human cytomegalovirus (HCMV) infections in immunosupressed patients provided the background for the emergence of the resistance to antivirals active against HCMV. In addition, laboratory selected mutants have also been readily achieved. Both clinical and laboratory resistant strains share the same determinants of resistance. Ganciclovir resistance may be due to a few mutations in the HCMV UL97 gene and/or viral DNA pol gene, the former being responsible for about 70% of clinical resistant isolates. Among them, V464, V594, S595 and F595 are the most frequent mutations. Because of their less extensive clinical use, much less is known about resistance to foscarnet and cidofovir (formerly, HPMPC) but in both cases, it has been associated to mutations in the DNA pol. Ganciclovir resistant strains showing DNA pol mutations are cross-resistant to cidofovir and their corresponding IC50 are normally higher than those from strains harboring only mutations at the UL97 gene. To date, foscarnet resistance seems to be independent of both ganciclovir and cidofovir resistance.
Similar articles
-
Generation and characterization of a GCV resistant HCMV UL97-mutation and a drug sensitive UL54-mutation.Antiviral Res. 2013 Dec;100(3):575-7. doi: 10.1016/j.antiviral.2013.09.026. Epub 2013 Oct 10. Antiviral Res. 2013. PMID: 24120366
-
Evolution of mutations conferring multidrug resistance during prophylaxis and therapy for cytomegalovirus disease.J Infect Dis. 1997 Sep;176(3):786-9. doi: 10.1086/517302. J Infect Dis. 1997. PMID: 9291334
-
[Mechanism of drug-resistance in human cytomegalovirus].Nihon Rinsho. 2007 Feb 28;65 Suppl 2 Pt. 1:476-9. Nihon Rinsho. 2007. PMID: 17455666 Review. Japanese. No abstract available.
-
Maribavir sensitivity of cytomegalovirus isolates resistant to ganciclovir, cidofovir or foscarnet.J Clin Virol. 2006 Oct;37(2):124-7. doi: 10.1016/j.jcv.2006.07.010. Epub 2006 Sep 8. J Clin Virol. 2006. PMID: 16962820
-
Clinical and biologic aspects of human cytomegalovirus resistance to antiviral drugs.Hum Immunol. 2004 May;65(5):403-9. doi: 10.1016/j.humimm.2004.02.007. Hum Immunol. 2004. PMID: 15172438 Review.
Cited by
-
Degradation of p21cip1 in cells productively infected with human cytomegalovirus.J Virol. 2001 Apr;75(8):3613-25. doi: 10.1128/JVI.75.8.3613-3625.2001. J Virol. 2001. PMID: 11264351 Free PMC article.